Lipid and protein oxidation and antioxidant status in patients with angiographically proven coronary artery disease

Clinical Biochemistry

Volumn 39, Issue 8, 2006, Pages 794-803

  Serdar, Zehra ^a   Aslan, Kemal ^a   Dirican, Melahat ^a   Sarandöl, Emre ^a   Yeşilbursa, Dilek ^a   Serdar, Akýn ^a  

^a ULUDAG UNIVERSITY   (Turkey)

Author keywords

Antioxidants; Coronary artery disease; Lipid peroxidation; Paraoxonase; Protein oxidation

Indexed keywords

ALPHA TOCOPHEROL; ANTIOXIDANT; APOLIPOPROTEIN A1; APOLIPOPROTEIN B; ARYLDIALKYLPHOSPHATASE; ARYLESTERASE; ASCORBIC ACID; CARBONYL DERIVATIVE; CAROTENOID; CATALASE; GLUCOSE 6 PHOSPHATE DEHYDROGENASE; GLUTATHIONE PEROXIDASE; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LIPID; LIPOPROTEIN; LOW DENSITY LIPOPROTEIN CHOLESTEROL; MALONALDEHYDE; OXIDIZING AGENT; PROTEIN; TRIACYLGLYCEROL;

ADULT; ANGIOCARDIOGRAPHY; ARTICLE; CARDIAC PATIENT; CHOLESTEROL BLOOD LEVEL; CONTROLLED STUDY; CORONARY ARTERY DISEASE; DISEASE ASSOCIATION; DISEASE SEVERITY; ENZYME ACTIVITY; ERYTHROCYTE; FEMALE; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; IN VITRO STUDY; LABORATORY TEST; LIPID OXIDATION; LIPOPROTEIN BLOOD LEVEL; MAJOR CLINICAL STUDY; MALE; MEDICAL PARAMETERS; OXIDATIVE STRESS; PRIORITY JOURNAL; SPECTROPHOTOMETRY; TRIACYLGLYCEROL BLOOD LEVEL; VITAMIN BLOOD LEVEL;

ANTIOXIDANTS; BLOOD PROTEINS; CORONARY ARTERIOSCLEROSIS; FEMALE; HUMANS; LIPID PEROXIDATION; LIPIDS; MALE; MIDDLE AGED; OXIDATION-REDUCTION;

EID: 33746911144     PISSN: 00099120     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.clinbiochem.2006.02.004     Document Type: Article

References (79)

1. Devasagayam T.P., Tilak J.C., Boloor K.K., Sane K.S., Ghaskadbi S.S., and Lele R.D. Free radicals and antioxidants in human health: current status and future prospects. J. Assoc. Phys. India 52 (2004) 794-804
2. Stocker R., and Keaney J.F. Role of oxidative modifications in atherosclerosis. Physiol. Rev. 84 (2004) 1381-1478
3. Stadtman E.R., and Levine R.L. Protein oxidation. Ann. N. Y. Acad. Sci. 899 (2000) 191-208
4. Hawkins C.L., and Davies M.J. Generation and propagation of radical reactions on proteins. Biochim. Biophys. Acta 1504 (2001) 196-219
5. Kaneda H., Taguchi J., Ogasawara K., Aizawa T., and Ohno M. Increased level of advanced oxidation protein products in patients with coronary artery disease. Atherosclerosis 162 (2002) 221-225
6. Schwenke D.C. Antioxidants and atherogenesis. J. Nutr. Biochem. 9 (1998) 424-445
7. Chen J., and Mehta J.L. Role of oxidative stress in coronary heart disease. Indian Heart J. 56 (2004) 163-173
8. Durrington P.N., Mackness B., and Mackness MI. Paraoxonase and atherosclerosis. Arterioscler. Thromb. Vasc. Biol. 21 (2001) 473-480
9. Jaouad L., Milochevitch C., and Khalil A. PON1 paraoxonase activity is reduced during HDL oxidation and is an indicator of HDL antioxidant capacity. Free Radic. Res. 37 (2003) 77-83
10. Aviram M., Rosenblat M., and Bisgaier CL. Paraoxonase inhibits high-density lipoprotein oxidation and preserves its functions. A possible peroxidative role for paraoxonase. J. Clin. Invest. 101 (1998) 1581-1590
11. Ng C.J., Shih D.M., Hama S.Y., Villa N., Navab M., and Reddy S.T. The paraoxonase gene family and atherosclerosis. Free Radic. Biol. Med. 38 (2005) 153-163
12. Gan K.N., Smolen A., Eckerson H.W., and LaDu B.N. Purification of human serum paraoxonase/arylesterase: evidence for one esterase catalyzing both activities. Drug Metab. Dispos. 19 (1991) 100-106
13. Frei B. On the role of vitamin C and other antioxidants in atherogenesis and vascular dysfunction. Proc. Soc. Exp. Biol. Med. 222 (1999) 196-204
14. Giugliano D. Dietary antioxidants for cardiovascular preventation. Nutr. Metab. Cardiovasc. Dis. 10 (2000) 38-44
15. Austen W.G., Edwards J.E., Frye R.L., et al. A reporting system on patients evaluated for coronary artery disease. Circulation 51 4 Suppl (1975) 5-40
16. Greenland P., Smith S.C., and Grundy S.M. Improving coronary heart disease assessment in asymptomatic people. Role of traditional risk factors and noninvasive cardiovascular tests. Circulation 104 (2001) 1863-1867
17. Friedewald W.T., Levy R.I., and Fredrickson D.S. Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of preparative ultracentrifuge. Clin. Chem. 18 (1972) 499-502
18. Young I.S., and Trimble E.R. Measurement of malondialdehyde in plasma by high performance liquid chromatography with fluorimetric detection. Ann. Clin. Biochem. 28 (1991) 504-508
19. Zhang A., Vertommen J., VanGaal L., and DeLeeuw I. A rapid and simple method for measuring the susceptibility of low-density-lipoprotein and very-low-density lipoprotein to copper-catalyzed oxidation. Clin. Chim. Acta 227 (1994) 159-173
20. Mosca L., Rubenfire M., Tarshis T., Tsai A., and Pearson T. Clinical predictors of oxidized low-density lipoprotein in patients with coronary artery disease. Am. J. Cardiol. 80 (1997) 825-830
21. Buege J.A., and Aust S.D. Microsomal lipid peroxidation. Methods Enzymol. 52 (1978) 302-310
22. Stocks J., Offerman E.L., Modell C.B., and Dormandy T.L. The susceptibility to autoxidation of human red cell lipids in health and disease. Brit. J. Haematol. 23 (1972) 713-724
23. Fairbanks V.F., and Klee G.G. Biochemical aspects of haematology. In: Burtis C.A., and Ashwood E.R. (Eds). Tietz textbook of clinical chemistry. 2nd ed. (1994), W.B. Saunders Co., Philadelphia 2020-2021
24. Reznick A.Z., and Packer L. Oxidative damage to proteins: spectrophotometric method for carbonyl assay. Methods Enzymol. 233 (1994) 357-363
25. Eckerson H.W., Wyte M.C., and LaDu B.N. The human serum paraoxonase/arylesterase polymorphism. Am. J. Hum. Genet. 35 (1983) 1126-1138
26. Haagen L., and Brock A. A new automated method for phenotyping arylesterase (E.C.3.1.1.2.) based upon inhibition of enzymatic hydrolysis of 4-nitrophenyl acetate by phenyl acetate. Eur. J. Clin. Chem. Clin. Biochem. 30 (1992) 391-395
27. Teissier E., Walters-Laporte E., Duhem C., Luc G., Fruchart J.C., and Duriez P. Rapid quantification of α-tocopherol in plasma and low- and high-density lipoproteins. Clin. Chem. 42 (1996) 430-435
28. McCormick D.B., and Greene H.L. Vitamins. In: Burtis C.A., and Ashwood E.R. (Eds). Tietz textbook of clinical chemistry. 2nd ed. (1994), W.B. Saunders Co., Philadelphia 313-314
29. Neeld J.B., and Pearson W.N. Macro- and micromethods for determination of serum vitamin A using trifluoroacetic acid. J. Nutr. 79 (1963) 454-462
30. Beutler E. Red cell metabolism: a manual of biochemical methods. 2nd ed. (1975), Grune and Starton, New York
31. Fairbanks V.F., and Klee G.G. Biochemical aspects of haematology. In: Burtis C.A., and Ashwood E.R. (Eds). Tietz textbook of clinical chemistry. 2nd ed. (1994), W.B. Saunders Co, Philadelphia 1982-1985
32. Goth L. A simple method for determination of serum catalase activity and revision of reference range. Clin. Chim. Acta 196 (1991) 143-151
33. Chiu H.C., Jeng J.R., and Shieh S.M. Increased oxidizability of plasma low density lipoprotein from patients with coronary artery disease. Biochim. Biophysica Acta 1225 (1994) 200-208
34. De Rijke Y.B., Verwey H.F., Vogelezang C.J., et al. Enhanced susceptibility of low-density lipoproteins to oxidation in coronary bypass patients with progression of atheroscerosis. Clin. Chim. Acta 243 (1995) 137-149
35. Regnström J., Nilsson J., Tornvall P., Landou C., and Hamsten A. Susceptibility to low density lipoprotein oxidation and coronary atherosclerosis in man. Lancet 339 (1992) 1183-1186
36. Croft K.D., Dimmitt S.B., Moulton C., and Beilin L.J. Low density lipoprotein composition and oxidizability in coronary disease-apparent favourable effect of beta blockers. Atherosclerosis 97 (1992) 123-130
37. Van de Vijver L., Kardinaal A., Duyvenvoorde W., et al. LDL oxidation and extent of coronary atherosclerosis. Arterioscler. Thromb. Vasc. Biol. 18 (1998) 193-199
38. Akkuş İ., Saǧlam N.I., Çaǧlayan O., Vural H., Kalak S., and Saǧlam M. Investigation of erythrocyte membrane lipid peroxidation and antioxidant defense systems of patients with coronary artery disease (CAD) documented by angiography. Clin. Chim. Acta 244 (1996) 173-180
39. Bridges A.B., Scott N.A., Pringle T.H., McNeill G.P., and Belch J.J. Relationship between the extent of coronary artery disease and indicators of free radical activity. Clin. Cardiol. 15 (1992) 169-174
40. Tamer L., Sucu N., Polat G., Ercan B., et al. Decreased serum total antioxidant status and erythrocyte-reduced glutathione levels are associated with increased serum malondialdehyde in atherosclerotic patients. Arch. Med. Res. 33 (2002) 257-260
41. Chevion M., Berenshtein E., and Stadtman E.R. Human studies related to protein oxidation: protein carbonyl content as a marker of damage. Free Radic. Res. 33 (2000) 99-108
42. Fu S., Davies M.J., Stocker R., and Dean R.T. Evidence for roles of radicals in protein oxidation in advanced human atherosclerotic plaque. Biochem. J. 333 (1998) 519-525
43. Heinecke J.W. Tyrosyl radical production by myeloperoxidase: a phagocyte pathway for lipid peroxidation and dityrosine cross-linking of proteins. Toxicology 177 (2002) 11-22
44. Miyata T., Inagi R., Asahi K., et al. Generation of protein carbonyls by glycoxidation and lipoxidation reactions with autoxidation products of ascorbic acid and polyunsaturated fatty acids. FEBS Lett. 437 (1998) 24-28
45. Tomas M., Latorre G., Senti M., and Marrugat J. The antioxidant function of high density lipoproteins: a new paradigm in atherosclerosis. Rev. Esp. Cardiol. 57 (2004) 557-569
46. Aviram M., Rosenblat M., Billecke S., et al. Human serum paraoxonase (PON 1) is inactivated by oxidized low density lipoprotein and preserved by antioxidants. Free Radic. Biol. Med. 26 (1999) 892-904
47. Navab M., Hama S.Y., Cooke C.J., et al. Normal high density lipoprotein inhibits three steps in the formation of mildly oxidized low density lipoprotein: step I. J. Lipid Res. 41 (2000) 1481-1494
48. Kabaro{eth}lu C., Mutaf I., Boydak B., et al. Association between serum paraoxonase activity and oxidative stress in acute coronary syndromes. Acta Cardiol. 59 (2004) 606-611
49. Mackness B., Davies G.K., Turkie W., et al. Paraoxonase status in coronary heart disease. Are activity and concentration more important than genotype?. Arterioscler. Thromb. Vasc. Biol. 21 (2001) 1451-1457
50. Azarsi{dotless}z E., Kayi{dotless}kci{dotless}oǧlu M., Payzi{dotless}n S., and Sözmen E.Y. PON1 activities and oxidative markers of LDL in patients with angiographically proven coronary artery disease. Int. J. Cardiol. 91 (2003) 43-51
51. Azizi F., Rahmani M., Raiszadeh F., Solati M., and Navab M. Association of lipids, lipoproteins, apolipoproteins and paraoxonase enzyme activity with premature coronary artery disease. Coron. Artery Dis. 13 (2002) 9-16
52. Rahmani M., Raiszadeh F., Allahverdian S., Kiaii S., Navab M., and Azizi F. Coronary artery disease is associated with the ratio of apolipoprotein B, but not with paraoxonase enzyme activity in Iranian subjects. Atherosclerosis 162 (2002) 381-389
53. Blankenberg S., Rupprecht H.J., Bickel C., et al. Glutathione peroxidase 1 activity and cardiovascular events in patients with coronary artery disease. N Engl. J. Med. 349 (2003) 1605-1613
54. Yegin A., Yegin H., Alicigüzel Y., Deǧer N., and Semiz E. Erythrocyte selenium-glutathione peroxidase activity is lower in patients with coronary atherosclerosis. Jpn. Heart J. 38 (1997) 793-798
55. Dubois-Rande J.L., Artigou J.Y., Darmon J.Y., et al. Oxidative stress in patients with unstable angina. Eur. Heart J. 15 (1994) 179-183
56. Nojiri S., Daida H., Mokuno H., et al. Association of serum antioxidant capacity with coranary artery disease in middle-aged men. Jpn. Heart J. 42 (2001) 677-690
57. Esterbauer H., Gebicki J., Puhl H., and Jurgens G. The role of lipid peroxidation and antioxidants in oxidative modification of LDL. Free Radic. Biol. Med. 13 (1992) 341-390
58. Gokce N., and Frei B. Basic research in antioxidant inhibition of steps in atherogenesis. J. Cardiovasc. Risk 3 (1996) 352-357
59. Sies H., and Stahl W. Vitamins E and C, β-carotene, and other carotenoids as antioxidants. Am. J. Clin. Nutr. 62 (1995) 1315-1322
60. Peng J., Jones G.L., and Watson K. Stress proteins as biomarkers of oxidative stress: effects of antioxidant supplements. Free Radic. Biol. Med. 28 (2000) 1598-1606
61. Gokce N., Keaney J.F., and Frei B. Long term ascorbic acid administration reverses endothelial vasomotor dysfunction in patients with coronary artery disease. Circulation 99 (1999) 3234-3240
62. Jialal I., and Grundy S.M. Effect of combined supplementation with α-tocopherol, ascorbate, and β carotene on low-density lipoprotein oxidation. Circulation 88 (1993) 2780-2786
63. Retsky K.L., and Frei B. Vitamin C prevents metal ion-dependant initiation and propagation of lipid peroxidation in human low-density lipoprotein. Biochim. Biophys. Acta 1257 (1995) 279-287
64. Martin A., and Frei B. Both intra- and extracellular vitamin C inhibit atherogenic modification of LDL by human vascular endothelial cells. Arterioscler. Thromb. Vasc. Biol. 17 (1997) 1583-1590
65. Carr A.C., and Frei B. Toward a new recommended dietary allowance for vitamin C based on antioxidant and health effects in humans. Am. J. Clin. Nutr. 69 (1999) 1086-1107
66. Erbs S., Gielen S., Linke A., et al. Improvement of peripheral endothelial dysfunction by acute vitamin C application: different effects in patients with coronary artery disease, ischemic, and dilated cardiomyopathy. Am. Heart J. 146 (2003) 280-285
67. Osganian S.K., Stampfer M.J., Rimm E., et al. Vitamin C and risk of coronary heart disease in women. J. Am. Coll. Cardiol. 42 (2003) 246-252
68. Osganian S.K., Stampfer M.J., Rimm E., Spiegelman D., Manson J.E., and Willett W.C. Dietary carotenoids and risk of coronary artery disease in women. Am. J. Clin. Nutr. 77 (2003) 1390-1399
69. Diaz M.N., Frei B., Vita J.A., and Keaney J.F. Antioxidants and atherosclerotic heart disease. N. Engl. J. Med. 337 (1997) 408-416
70. Maxwell S.R., and Lip G.Y. Free radicals and antioxidants in cardiovascular disease. Br. J. Clin. Pharmacol. 44 (1997) 307-317
71. Rimm E.H., Stampfer M.J., Ascherio A., Giovannucci E.L., Colditz G.A., and Willett W.C. Vitamin E consumption and the risk of coronary disease in men. N. Engl. J. Med. 328 (1993) 1450-1456
72. Stampfer M.J., Hennekins C.H., Manson J.E., Colditz G.A., Rosner B., and Willett W.C. Vitamin E consumption and the risk of coronary disease in women. N. Engl. J. Med. 328 (1993) 1444-1449
73. Yusoff K. Vitamin E in cardiovascular disease: has the die been cast?. Asia Pac. J. Clin. Nutr. 11 (2002) 443-447
74. Esterbauer H., Dieber-Rotheneder M., Striegl G., and Waegl G. Role of vitamin E in preventing the oxidation of low-density lipoprotein. Am. J. Clin. Nutr. 53 (1991) 314-321
75. Princen H.M.G., van Poppel G., Vogelezang C., Buytenhek R., and Kok F.J. Supplementation with vitamin E but not β-carotene in vivo protects low density lipoprotein from lipid peroxidation in vitro: effect of cigarette smoking. Arterioscler. Thromb. 12 (1992) 554-562
76. Reaven P.D., Khouw A., Beltz W.F., Parthasarathy S., and Witztum J.L. Effect of dietary antioxidant combinations in humans: protection of LDL by vitamin E but not by β-carotene. Arterioscler. Thromb. 13 (1993) 590-600
77. Abbey M., Nestel P.J., and Baghurst P.A. Antioxidant vitamins and low-density-lipoprotein oxidation. Am. J. Clin. Nutr. 58 (1993) 525-532
78. Dixon Z.R., Shie F.S., Warden B.A., Burri B.J., and Neidlinger T.R. The effect of a low carotenoid diet on malondialdehyde-thiobarbituric acid (MDA-TBA) concentrations in women: a placebo-controlled double-blind study. J. Am. Coll. Nutr. 17 (1998) 54-58
79. Singh R.B., Ghosh S., Niaz M.A., et al. Dietary intake, plasma levels of antioxidant vitamins, and oxidative stress in relation to coronary artery disease in elderly subjects. Am. J. Cardiol. 76 (1995) 1233-1238